Market Sectors: Laboratories

Featured Articles

Abbott: Discards plans to sell vaccine business Comment

Abbott: Discards plans to sell vaccine business

Abbott Laboratories has abandoned its plan to sell its vaccines business.
Pyng Medical Corp: Gets FDA approval Comment

Pyng Medical Corp: Gets FDA approval

Pyng Medical Corp has received 510(k) clearance from the U.S. FDA for their FASTx(TM) Sternal Intraosseous Device.
Fortis Healthcare: Will open IPO in 2011 Comment

Fortis Healthcare: Will open IPO in 2011

Fortis Healthcare plans to launch an IPO for its diagnostics business called Super Religare Laboratories in 2011.
Graphene Lab & CVD Equipment offer new products Comment

Graphene Lab & CVD Equipment offer new products

CVD Equipment Corporation & Graphene Laboratories Inc launched a new array of CVD Graphene products today.
GE and Intel: Collaborates to set a health care company Comment

GE and Intel: Collaborates to set a health care company

General Electric Co. and Intel Corp. are forming a joint venture to create a new health care company.
Lawsuit settlement: Silicon Laboratories & Quintic Comment

Lawsuit settlement: Silicon Laboratories & Quintic

Silicon Laboratories has settled its patent infringement lawsuit against Quintic Corporation.
RiskMetrics recommends Charles River Laboratories to vote against China’s Wuxi P Comment

RiskMetrics recommends Charles River Laboratories to vote against China’s Wuxi Pharma Tech deal

Proxy voting advisory firm RiskMetrics advised shareholders of pharmaceutical research company, Charles River Laboratories to vote against its planned acquisition of China’s WuXi PharmaTech.
India’s Dr Reddy Laboratories: Signs MoU with an Australian pharma company Comment

India’s Dr Reddy Laboratories: Signs MoU with an Australian pharma company

Indian pharmaceutical major, Dr. Reddy Laboratories, has signed an agreement with Alchemia, an Australian pharmaceutical company, in order to market Fondaparinux sodium for injection in markets outside of North America.
Glaxo: Diabetes Pill under examination Comment

Glaxo: Diabetes Pill under examination

The Food and Drug Administration will review the safety of the British drug – the diabetes pill, Avandia, for the second time in 3 years.
A simple test can now detect diabetes well in advance Comment

A simple test can now detect diabetes well in advance

A new medical discovery could lead to a simple, routine test that can perceive the initial stages of diabetes, according to scientists.